Quick Takeaways
- AQR CAPITAL MANAGEMENT LLC filed SCHEDULE 13G for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT).
- Disclosed ownership: 7.7%.
- Date of event: 31 Dec 2025.
AQR CAPITAL MANAGEMENT LLC - 31 Dec 2025 SCHEDULE 13G Report for Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT)
- Filing Manager
- AQR CAPITAL MANAGEMENT LLC
- Reporting Manager
- AQR Capital Management, LLC
- Symbol
- SRPT
- Shares outstanding
- 104,849,534 shares
- Disclosed Ownership
- 8,104,869 shares
- Ownership
- 7.7%
- Form type
- SCHEDULE 13G
- Filing time
- 13 Feb 2026, 11:52:53 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"AQR CAPITAL MANAGEMENT LLC disclosed 7.7% ownership in Sarepta Therapeutics, Inc. Common Stock, $0.0001 par value per share (SRPT) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Feb 2026, 11:52.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| AQR Capital Management, LLC | 7.7% | 8,104,869 | 0 | 8,104,869 | Henry Parkin | Authorized Signatory | |
| AQR Capital Management Holdings, LLC | 7.7% | 8,104,869 | 0 | 8,104,869 | Henry Parkin | Authorized Signatory |